Boston Scientific Corp (BSX)vsInspire Medical Systems Inc (INSP)
BSX
Boston Scientific Corp
$48.55
-0.55%
HEALTHCARE · Cap: $70.87B
INSP
Inspire Medical Systems Inc
$41.19
-2.37%
HEALTHCARE · Cap: $1.23B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 2152% more annual revenue ($20.61B vs $915.25M). BSX leads profitability with a 17.3% profit margin vs 14.3%. INSP trades at a lower P/E of 9.7x. BSX earns a higher WallStSmart Score of 76/100 (B+).
BSX
Strong Buy76
out of 100
Grade: B+
INSP
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.4%
Fair Value
$37.35
Current Price
$48.55
$11.20 premium
Margin of Safety
+85.3%
Fair Value
$462.74
Current Price
$41.19
$421.55 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 308.4% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
No major concerns identified
1.6% revenue growth
Smaller company, higher risk/reward
Operating margin of -0.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : INSP
The strongest argument for INSP centers on P/E Ratio, Price/Book, EPS Growth.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : INSP
The primary concerns for INSP are Revenue Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
BSX profiles as a mature stock while INSP is a value play — different risk/reward profiles.
INSP carries more volatility with a beta of 0.73 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (76/100 vs 56/100), backed by strong 17.3% margins and 11.6% revenue growth. INSP offers better value entry with a 85.3% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Inspire Medical Systems Inc
HEALTHCARE · MEDICAL DEVICES · USA
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?